Sept. 12, 2013
/PRNewswire/ -- Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts (NASDAQ: MDRX) and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.
Advanced healthcare technologies are needed for the payer, provider, and patient to succeed together. With this agreement, Inovalon will apply its advanced quality improvement and risk score accuracy analytics to Allscripts EHR Platform, improving the speed and workflow efficiency of data exchanges within the medical record process between payers and providers.
"Payers and providers increasingly enter into shared risk relationships to improve clinical and quality outcomes as well as financial performance within the broader healthcare environment," said
, M.D., President and Chief Executive Officer of Inovalon. "We are pleased to be working with Allscripts to bring these technological advancements to payers and clinicians across the country."
The combination of thousands of disease, diagnosis, treatment, and care considerations together with the expanding complexity of regulatory oversight, quality measurement requirements, reimbursement models, and healthcare organization structures has resulted in a significant increase in burden within the healthcare landscape. Today, payers and providers alike must maintain extensive resources and subject matter expertise in an effort to comply, let alone excel, in the current environment. Additionally, in order to substantiate performance and regulatory adherence with such programs as NCQA HEDIS
quality performance measurement, the CMS Five-Star Quality Rating program, and other federal and state-based risk score accuracy programs, providers and payers must support extensive medical record review initiatives. Through the integration of analytics and electronic medical record data abstraction, the integration of Inovalon's toolsets within the Allscripts environment decreases the burden for both the payer and the provider while increasing quality outcomes and risk score data accuracy.
"With the expansion of complex managed-care program environments, data-driven platforms have become increasingly crucial for all segments of the healthcare continuum," said
, General Manager, Payer & Life Sciences for Allscripts. "Our collaboration with Inovalon provides payers with valuable insights and improvement capabilities so that they, in turn, can more effectively partner with providers to drive more efficient and effective care."
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit
It Takes A Community: The Allscripts Blog.
About Inovalon, Inc.
Inovalon, Inc. is a leading technology-enabled healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvement in clinical and quality outcomes, care management and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess and deep human resources, empower Inovalon's advanced generation of healthcare assessment and improvement through highly informed solutions. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance -- while also bringing to bear the resources to resolve them. This differentiating combination provides a powerful capability suite, touching more than 540,000 physicians, 220,000 clinical facilities, and more than 120 million Americans, driving high‐value impact, improving the quality and economics for health plans, hospitals, physicians, patients, and researchers. Please visit
for more information.
SOURCE Inovalon, Inc.